CS logo
small CS logo
Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)

Rio De Janeiro, Brazil
Instituto de pesquisa científica no Rio de Janeiro

About Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)


During the past decade, Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI) conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
2017-10-05
2024-08-16
Active, not recruiting
416
A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
2017-10-27
2023-12-26
Active, not recruiting
522
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
2017-11-07
2025-12-22
Active, not recruiting
390
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
2018-04-05
2024-01-31
Active, not recruiting
125
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
2019-01-25
2027-02-19
Active, not recruiting
765
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
2019-04-22
2022-11-29
Completed
14,532
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab
2019-05-31
2023-01-10
Terminated
88
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
2020-02-28
2024-03-29
Recruiting
105

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 13Janssen Research &Development, LLC: 13

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)


According to Clinical.Site data, the most researched conditions in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" are "Multiple Myeloma" (3 trials), "Relapsed or Refractory Multiple Myeloma" (2 trials), "Amyloidosis" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Castration-Resistant Prostatic Cancer" (1 trials). Many other conditions were trialed in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" in a lesser frequency.

Clinical Trials Intervention Types at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)


Most popular intervention types in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (3 trials), "Daratumumab" (3 trials), "Dexamethasone" (3 trials), "Pomalidomide" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)


The vast majority of trials in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" are 10 trials for "All" genders and 3 trials for "Male" genders.

Clinical Trials Status at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)


Currently, there are NaN active trials in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 6Recruiting: 6Active, not recruiting: 5Active, not recruiting: 5Completed: 1Completed: 1Terminated: 1Terminated: 1